Zortress Tablet
Product Images NDC 0078-0415

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zortress (NDC 0078-0415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zortress Structural Formula Of Everolimus Is (1r, 9s, 12s, 15r, 16e, 18r, 19r, 21r, 23s, 24e, 26e, 28e, 30s, 32s, 35r)-1, 18-dihydroxy-12 -{(1r)-2-[(1s,3r,4r)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] Hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. (Zortress 01)

Zortress Structural Formula Of Everolimus Is (1r, 9s, 12s, 15r, 16e, 18r, 19r, 21r, 23s, 24e, 26e, 28e, 30s, 32s, 35r)-1, 18-dihydroxy-12 -{(1r)-2-[(1s,3r,4r)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] Hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. (Zortress 01)
FDA Label Image

Principal Display Panelpackage Label – 0.25 mgrx Only Ndc 0078-0417-20zortress® (everolimus) Tablets (Zortress 02)

Principal Display Panelpackage Label – 0.25 mgrx Only Ndc 0078-0417-20zortress® (everolimus) Tablets (Zortress 02)
This appears to be a product description for a medication called "& ZORTRESS (Everolimus) Tablets" in two different languages. The dosage is listed as 0.25mg per tablet and there is some information about the packaging. However, there is a lot of missing information and unclear formatting, making it difficult to understand the full context of the text.*
FDA Label Image

Principal Display Panelpackage Label – 0.5 mgrx Only Ndc 0078-0414-20zortress® (everolimus) Tablets (Zortress 03)

Principal Display Panelpackage Label – 0.5 mgrx Only Ndc 0078-0414-20zortress® (everolimus) Tablets (Zortress 03)
Wooomsastez Fonly (everolimus) Tablets are available in 0.5 mg per tablet strength.*
FDA Label Image

Principal Display Panelpackage Label – 0.75 mgrx Only Ndc 0078-0415-20zortress® (everolimus) Tablets (Zortress 04)

Principal Display Panelpackage Label – 0.75 mgrx Only Ndc 0078-0415-20zortress® (everolimus) Tablets (Zortress 04)
The text is related to a medication called Everolimus available in the form of tablets. No further information is available.*
FDA Label Image

Figure 1. Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73m2] By Visit Window And Treatment After Liver Transplantation (itt Population 24 Month Analysis)* (Zortress 05)

Figure 1. Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73m2] By Visit Window And Treatment After Liver Transplantation (itt Population 24 Month Analysis)* (Zortress 05)
This text provides information about a medical test result. The GFR (glomerular filtration rate) was measured using the MDRD 4 formula, and the result was 110 mL/min/1.73m^2. The remaining text indicates visit windows and treatment groups for a clinical trial, and is not relevant to the medical test result.*
FDA Label Image

Zortress 06

Zortress 06

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.